Novartis exited novel antibiotics R&D three years ago, but is clearly still interested in the category – its Sandoz unit has just spent $350 million buying GlaxoSmithKline’s cephalosporin franchise.
A comprehensive Model Context Protocol (MCP) server that provides advanced pharmaceutical intelligence through the FDA's openFDA database. This server combines real-time data access, intelligent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback